Search by Drug Name or NDC

    NDC 65162-0925-50 Lacosamide 150 mg/1 Details

    Lacosamide 150 mg/1

    Lacosamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is LACOSAMIDE.

    Product Information

    NDC 65162-0925
    Product ID 65162-925_4bc450e0-da81-432e-aef3-9e7c8fee8be0
    Associated GPIs 72600036000340
    GCN Sequence Number 064434
    GCN Sequence Number Description lacosamide TABLET 150 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14341
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Generic
    Proprietary Name Lacosamide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lacosamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name LACOSAMIDE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA204857
    Listing Certified Through 2024-12-31

    Package

    NDC 65162-0925-50 (65162092550)

    NDC Package Code 65162-925-50
    Billing NDC 65162092550
    Package 500 TABLET in 1 BOTTLE (65162-925-50)
    Marketing Start Date 2022-03-21
    NDC Exclude Flag N
    Pricing Information N/A